Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Larson

Showing results (251-260 of 1,403) with videos related to

Pageof 141
Sort By:
Risk Analysis : an Official Publication of the Society for Risk Analysis|May 15, 2022
Vaccines and the social amplification of riskHeidi J Larson, Leesa Lin, Rob Goble
Vaccine: X|October 4, 2022
A mixed methods study of health care professionals' attitudes towards vaccination in 15 countriesAbrar Alasmari, Heidi J Larson, Emilie Karafillakis
Molecular & General Genetics : MGG|March 1, 1986
Physical and genetic structure of the glpD-malT interval of the Escherichia coli K-12 chromosome. Identification of two new structural genes of the glp-regulonH Schweizer, G Sweet, T J Larson
Brain Research|October 13, 1999
Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP miceJ Larson, G Lynch, D Games, et al.
Journal of Dental Research|October 1, 1996
Saliva protein binding to streptococcal layers placed at different oral sites in 48 personsJ D Rudney, Z Ji, C J Larson
Neuroreport|February 10, 2011
Sex differences in error-related performance monitoringMichael J Larson, Mikle South, Peter E Clayson
Medical Hypotheses|April 3, 2007
The potential impact of sickness-motivated behavior on the expression of neuropsychiatric disturbances in systemic lupus erythematosusThomas J Santoro, Michiyo Tomita, Susan J Larson
Molecular Microbiology|May 1, 1997
Action at a distance for glp repressor control of glpTQ transcription in Escherichia coli K-12B Yang, S G Gerhardt, T J Larson
Vaccine|November 22, 2022
COVID-19 vaccine acceptance and its socio-demographic and emotional determinants: A multi-country cross-sectional studyA de Figueiredo, C Simas, H J Larson
The Lancet. Infectious Diseases|April 3, 2016
A hepatitis-free future: strategy first, then pricingHeidi J Larson, Pierre Van Damme, David FitzSimons
Pageof 141

Showing results (251-260 of 1,403) with videos related to

Sort By:
Pageof 141
Risk Analysis : an Official Publication of the Society for Risk Analysis|May 15, 2022
Vaccines and the social amplification of riskHeidi J Larson, Leesa Lin, Rob Goble
Vaccine: X|October 4, 2022
A mixed methods study of health care professionals' attitudes towards vaccination in 15 countriesAbrar Alasmari, Heidi J Larson, Emilie Karafillakis
Molecular & General Genetics : MGG|March 1, 1986
Physical and genetic structure of the glpD-malT interval of the Escherichia coli K-12 chromosome. Identification of two new structural genes of the glp-regulonH Schweizer, G Sweet, T J Larson
Brain Research|October 13, 1999
Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP miceJ Larson, G Lynch, D Games, et al.
Journal of Dental Research|October 1, 1996
Saliva protein binding to streptococcal layers placed at different oral sites in 48 personsJ D Rudney, Z Ji, C J Larson
Neuroreport|February 10, 2011
Sex differences in error-related performance monitoringMichael J Larson, Mikle South, Peter E Clayson
Medical Hypotheses|April 3, 2007
The potential impact of sickness-motivated behavior on the expression of neuropsychiatric disturbances in systemic lupus erythematosusThomas J Santoro, Michiyo Tomita, Susan J Larson
Molecular Microbiology|May 1, 1997
Action at a distance for glp repressor control of glpTQ transcription in Escherichia coli K-12B Yang, S G Gerhardt, T J Larson
Vaccine|November 22, 2022
COVID-19 vaccine acceptance and its socio-demographic and emotional determinants: A multi-country cross-sectional studyA de Figueiredo, C Simas, H J Larson
The Lancet. Infectious Diseases|April 3, 2016
A hepatitis-free future: strategy first, then pricingHeidi J Larson, Pierre Van Damme, David FitzSimons
Pageof 141